BRPI0907495A2 - sulfonamidas de imidazolinilmetil arila - Google Patents

sulfonamidas de imidazolinilmetil arila

Info

Publication number
BRPI0907495A2
BRPI0907495A2 BRPI0907495-3A BRPI0907495A BRPI0907495A2 BR PI0907495 A2 BRPI0907495 A2 BR PI0907495A2 BR PI0907495 A BRPI0907495 A BR PI0907495A BR PI0907495 A2 BRPI0907495 A2 BR PI0907495A2
Authority
BR
Brazil
Prior art keywords
aryl sulfonamides
methods
imidazolinylmethyl
imidazolinylmethyl aryl
formula
Prior art date
Application number
BRPI0907495-3A
Other languages
English (en)
Inventor
O'yang Counde
Mitsugu Yasuda Dennis
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of BRPI0907495A2 publication Critical patent/BRPI0907495A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

sulfonamidas de imidazolinilmetil arila. a presente invenção refere-se a um agonista parcial do receptor alfa-1a, que é representado pela fórmula (i) e seus sais ou solvatos farmaceuticamente aceitáveis. a invenção ainda se refere as composições farma- cêuticas contendo a fórmula i, os métodos para o seu uso como agentes terapêuticos e métodos para a sua preparação.
BRPI0907495-3A 2008-02-04 2009-01-26 sulfonamidas de imidazolinilmetil arila BRPI0907495A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2583608P 2008-02-04 2008-02-04
US60/025,8396 2008-02-04
PCT/EP2009/050837 WO2009098133A1 (en) 2008-02-04 2009-01-26 Novel imidazolinylmethyl aryl sulfonamides

Publications (1)

Publication Number Publication Date
BRPI0907495A2 true BRPI0907495A2 (pt) 2019-02-26

Family

ID=40456344

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0907495-3A BRPI0907495A2 (pt) 2008-02-04 2009-01-26 sulfonamidas de imidazolinilmetil arila

Country Status (12)

Country Link
US (1) US20090197933A1 (pt)
EP (1) EP2238115B1 (pt)
JP (1) JP2011511023A (pt)
KR (1) KR20100096266A (pt)
CN (1) CN101925579A (pt)
AT (1) ATE531697T1 (pt)
AU (1) AU2009211503A1 (pt)
BR (1) BRPI0907495A2 (pt)
CA (1) CA2711724A1 (pt)
IL (1) IL206763A0 (pt)
MX (1) MX2010008019A (pt)
WO (1) WO2009098133A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4204404A4 (en) * 2020-08-27 2024-12-25 Curasen Therapeutics, Inc. Alpha1a-adrenergic receptor agonists and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
AU2003227623B2 (en) * 2002-04-23 2010-05-20 F. Hoffmann-La Roche Ag Imidazolinylmethyl aralkylsulfonamides

Also Published As

Publication number Publication date
KR20100096266A (ko) 2010-09-01
EP2238115B1 (en) 2011-11-02
US20090197933A1 (en) 2009-08-06
ATE531697T1 (de) 2011-11-15
EP2238115A1 (en) 2010-10-13
IL206763A0 (en) 2010-12-30
CA2711724A1 (en) 2009-08-13
CN101925579A (zh) 2010-12-22
MX2010008019A (es) 2010-08-10
JP2011511023A (ja) 2011-04-07
WO2009098133A1 (en) 2009-08-13
AU2009211503A1 (en) 2009-08-13

Similar Documents

Publication Publication Date Title
EA201390908A1 (ru) Производные бицикло[3.2.1]октиламида и их применение
MX390264B (es) Antagonistas d2, metodos de sintesis y metodos de uso.
ATE517882T1 (de) Chinolinderivate
EA201001724A1 (ru) Производные изоксазола и их применение в качестве потенциирующих средств для метаботропных глутаматных рецепторов
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
EA200970156A1 (ru) Пиридизиноновые производные
MX2013005826A (es) Benzoxazepinas como inhibidores de fosfatidilinositol 3-cinasa/objetivo de rapamicina en mamiferos (p13k/mtor) y metodos de uso y fabricacion.
IL189191A0 (en) Thiazolyl piperidine derivatives useful as h3 receptor modulators
EA201291217A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПРОИЗВОДНЫЕ 1-(β-D-ГЛЮКОПИРАНОЗИЛ)-2-ТИЕНИЛМЕТИЛБЕНЗОЛА КАК ИНГИБИТОРЫ НЗПГ
GEP20135744B (en) Quinuclidine carbonate derivatives and medicinal compositions containing the same
EA200900135A1 (ru) Производные пиразола в качестве ингибиторов цитохрома р450
NO20091741L (no) Pyrazolinforbindelser som mineralkortikoidreceptorantagonister
EA201390163A1 (ru) Гетеробициклические производные в качетстве ингибиторов hcv
UA100877C2 (ru) Замещенные спироциклические производные пиперидина как лиганды рецепторов гистамина-3 (h3)
UA109290C2 (uk) Спільні кристали і солі інгібіторів ccr3
EA201290229A1 (ru) Производные спиролактама и их применение
EA201391524A1 (ru) Производные гликозида и их применение
EA201001566A1 (ru) Новый класс спиропиперидинов для лечения нейродегенеративных заболеваний
EA201290534A1 (ru) Бициклические тиазолы в качестве аллостерических модуляторов mglur5 рецепторов
EA201270556A1 (ru) Конденсированные тиазоло и оксазолопиримидиноны
MX2010007929A (es) Imidazolinilmetil aril sulfonamidas novedosas.
ATE546448T1 (de) Urotensin-ii-rezeptorantagonisten
DE602007005387D1 (de) Ptors
MX2010007928A (es) Imidazolinilmetil aril sulfonamidas novedosas.
BRPI0907495A2 (pt) sulfonamidas de imidazolinilmetil arila

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A, 7A, 8A, 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2513 DE 06-03-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]